BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2547197)

  • 21. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer].
    Kosuda S; Kondo M; Masaki H; Endo M; Ando Y; Takagi Y; Kubo A; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 May; 42(5):454-66. PubMed ID: 6217442
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
    Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
    Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone scintigraphy of non-ossifying fibroma].
    Sato Y; Nakayama C; Nakata H; Suzuki K
    Rinsho Hoshasen; 1988 Feb; 33(2):265-9. PubMed ID: 3385950
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
    Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
    Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of solitary hot spots of bone scintigraphy in patients with extraskeletal malignancies].
    Tomoda Y; Ishino Y; Nakata H
    Kaku Igaku; 2001 Nov; 38(6):721-6. PubMed ID: 11806083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The roentgenologic manifestations of primary malignant fibrous histiocytoma (MFH) of the bone].
    Xie DZ
    Zhonghua Fang She Xue Za Zhi; 1986 Jun; 20(3):142-5. PubMed ID: 3019615
    [No Abstract]   [Full Text] [Related]  

  • 27. [Skeletal scintigraphy in hemangioma of the bones].
    Smirnov IuN; Podliashchuk EL; Rassokhin BM; Ustinova VF
    Med Radiol (Mosk); 1988 Apr; 33(4):16-21. PubMed ID: 3357384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant fibrous histiocytoma of bone.
    Boland PJ; Huvos AG
    Clin Orthop Relat Res; 1986 Mar; (204):130-4. PubMed ID: 3006959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign fibrous histiocytoma of bone.
    Bertoni F; Calderoni P; Bacchini P; Sudanese A; Baldini N; Present D; Campanacci M
    J Bone Joint Surg Am; 1986 Oct; 68(8):1225-30. PubMed ID: 3021777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malignant fibrous histiocytoma accompanied by massive osteolysis].
    Otani Y; Yamamoto I; Kawana M
    Rinsho Hoshasen; 1990 Aug; 35(8):947-8. PubMed ID: 2170708
    [No Abstract]   [Full Text] [Related]  

  • 31. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone and gallium scan findings in malignant fibrous histiocytoma. Case report with radiographic and pathologic correlation.
    Mackey JK; Alexieva-Jackson B; Fetters DV; Edwards SM; McBride JP; Cole RL; Trapp WG
    Clin Nucl Med; 1987 Jan; 12(1):17-21. PubMed ID: 3028689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic significance of the clinical x-ray and morphological signs in malignant fibrous histiocytoma of bone].
    Petrovichev NN; Khmelev ON; Annamukhamedov A; Dvorova EK
    Vopr Onkol; 1987; 33(12):33-8. PubMed ID: 2827391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of malignant fibrous histiocytoma (MFH) in the skull bone presenting extensive permeative osteolysis.
    Woodhams R; Kan S; Iwabuchi K; Oka H; Sagiuchi T; Hayakawa K
    Radiat Med; 2002; 20(3):141-5. PubMed ID: 12126088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of malignant and degenerative bone lesions using dexamethasone interventional 3- and 24-hour bone scintigraphy.
    Bhatnagar A; Mondal A; Kashyap R; Sharma RK; Sharma R; Chakravarty SK; Bihari V; Sawroop K; Chopra MK; Soni NL
    Eur J Nucl Med; 1994 Jul; 21(7):609-14. PubMed ID: 7957346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m diphosphonate uptake in malignant fibrous histiocytoma: a possible iron-related effect.
    Spencer RP; Evans DD; Forouhar F; Fetters DV; Yeh SD
    Clin Nucl Med; 1988 Oct; 13(10):734-5. PubMed ID: 2846223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB).
    Schmall B; Conti PS; Bigler RE; Zanzonico PB; Reiman RE; Benua RS; Yeh SD; Dahl JR; Lee R; Laughlin JS
    Clin Nucl Med; 1987 Jan; 12(1):22-6. PubMed ID: 3028690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation.
    Murphey MD; Gross TM; Rosenthal HG
    Radiographics; 1994 Jul; 14(4):807-26; quiz 827-8. PubMed ID: 7938770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of bone scintigraphy to select patients with multiple myeloma for treatment with strontium-89.
    Edwards GK; Santoro J; Taylor A
    J Nucl Med; 1994 Dec; 35(12):1992-3. PubMed ID: 7989983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The occasional diagnosis of Plummer's disease during bone scintigraphy with 99mTc-HMDP].
    Saletnich I; Salvatori M; Summaria V; Giordano A
    Radiol Med; 1995 Apr; 89(4):551-4. PubMed ID: 7597246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.